Podcast appearances and mentions of Arturo Casadevall

Matters Microbial #82: Melanin, Fungi, and Global Warming March 13, 2025 Today, the impressive Dr. Arturo Casadevall of Johns Hopkins University returns to the podcast to discuss how fungal disease is a looming threat on our warming planet, and how these organisms can use pigmentation to adapt to human-associated environments . . . and increase their chances of causing disease. Host: Mark O. Martin Guest: Arturo Casadevall Subscribe: Apple Podcasts, Spotify Become a patron of Matters Microbial! Links for this episode A video overview of the understudied world of fungi. A CDC overview of fungal diseases. A hopeful study:  fungi, frogs, and purple bacteria.  A less scholarly but highly recommended essay is here. Dr. Casadevall's earlier visit to #MattersMicrobial. The story of Alexander Fleming, a stray fungal spore, and penicillin. The story of fungi and cyclosporins, which help with organ transplantation in humans. A recent New York Times article on fungal networks. An article about mass extinctions and “fungal overgrowth.” A review of the structure and function of melanin. An overview of how melanin can be used to turn various forms of radiation into energy. A review of high body temperatures versus fungal infections. One of the articles discussed today, from Dr. Casadevall's group:  “Impact of Yeast Pigmentation on Heat Capture and Latitudinal Distribution.” Another article from Dr. Casadevall's group discussed today:  “The hypothermic nature of fungi.” A really fascinating preprint from Dr. Casadevall's group discussed today:  “Thermal and pigment characterization of environmental fungi in the urban heat island of Baltimore City” Dr. Casadevall's faculty website. The research website for Dr. Casadevall's group. Intro music is by Reber Clark Send your questions and comments to mattersmicrobial@gmail.com

Our body temperature is currently too hot for fungus to thrive in – which is why we don't often have to worry about a serious fungal infection. However, global warming is forcing fungi to evolve to withstand hotter temperatures, which could be bad news for humanity. Dr. Arturo Casadevall explains what a future fungal pandemic might look like. Learn More: https://radiohealthjournal.org/how-a-fungal-pandemic-could-create-real-life-zombies Learn more about your ad choices. Visit megaphone.fm/adchoices

About this episode: The first of a series of podcasts about vaccine basics from the molecular level to global policy and everything in between. What actually are vaccines and how do they work? In this episode: back to basics on vaccines and immunology with Dr. Arturo Casadevall and Dr. Josh Sharfstein, including a discussion on why we still don't have a vaccine for HIV. Guest: Arturo Casadevall is chair of the department of Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health and an infectious disease physician with more than 30 years of experience studying vaccines. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: How do we know that vaccines work?–HHS Understanding the Impact and Importance of Childhood Vaccinations—Yale School of Public Health Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed

Five years after COVID became a global pandemic, could another health crisis be on our horizon? According to scientists who study diseases, the possibility of a fungal pandemic—the subject of science fiction TV shows like “The Last of Us,” could be more of a reality, thanks to climate change and our warming planet. As fungi are adapting to warmer climates, they are becoming increasingly stronger and more resistant against the drugs we have to fight them.Arturo Casadevall is one of the scientists who is warning against fungi's powerful potential. He's a professor of microbiology and immunology at the Johns Hopkins' Bloomberg School of Public Health and the author of the new book, What If Fungi Win? He explains why fungi are becoming a growing public health threat, and what tools we have to protect ourselves from a future fungal outbreak.

Over six million fungal species are believed to inhabit planet Earth. Outsmarting them is the work of Arturo Casadevall's lifetime. What If Fungi Win? is the question at the heart of Arturo's new book, co-authored with journalist Stephanie Desmon. In this episode, Emily and Regina take a trip to Arturo's lab at Johns Hopkins University in Baltimore and meet a group of scientists thinking about the fungal consequences of climate change, urban heat islands, and scooping up microbes with candy. Curious about fungi? Email us at shortwave@npr.org — we'd love to hear from you!Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Mention the word 'fungi' and it's likely many of our minds will turn to the mushrooms we enjoy sliced on the top of our favourite pizza or bowl of pasta. But there's more to these fascinating organisms than this. Without fungi we'd have no yeast to make bread or brew beer and no penicillin to treat infections. In this episode, we catch up physician and immunology researcher Arturo Casadevall to talk about his latest book What if Fungi Win? He tells us about the essential role fungi plays in the ecosystems and lifecycles of the Earth, how they pose a potential threat to our food supplies, the role climate change is playing in the evolution of fungi and the role they may possibly play in combatting it. Learn more about your ad choices. Visit podcastchoices.com/adchoices

What's your favorite fungus? You might say mushrooms and stop there, since for most of us a broad knowledge of fungi is lacking. Arturo Casadevall, Johns Hopkins professor and author of a new book, “What if the Fungi Win?” is … Fungi are worth your attention, Elizabeth Tracey reports Read More »

Most of the world's population is dependent on grains for survival, and if fungal attacks on these food sources continue to increase, starvation of many of us is possible. That's according to Arturo Casadevall, author of “Will the Fungi Win,” … Devastation of food crops is one of fungi's biggest threats to people, Elizabeth Tracey reports Read More »

The summer of 2024 is shaping up to be among the hottest on record, and for fungi, that may be just the stimulus needed to enable them to effectively infect humans. That's according to Johns Hopkins professor Arturo Casadevall in … Fungi are becoming more adapted to hot temperatures, and that may lead to more human infections, Elizabeth Tracey reports Read More »

Fungal infections of people are on the rise, Arturo Casadevall, Johns Hopkins professor and author of “Will the Fungi Win?” states. That's true because climate change is stimulating the organisms to become more capable of thriving at body temperatures, which … What is the best strategy to mitigate the impact of fungal infections in people? Elizabeth Tracey reports Read More »

Fungal kingdom frontiersman Dr. Arturo Casadevall, asks, What if Fungi Win? Michael Schmidt and Mark O. Martin discuss with Arturo, his new book and the beneficial roles of fungi along with their mischievous and deadly impacts and how committed experts are researching ways to save us and our food supplies. Hosts: Michael Schmidt, Mark O. Martin Guest: Dr. Arturo Casadevall Watch this episode: https://youtu.be/nKJe5xNUocU Become a patron of TWiM. Links for this episode Recorded at ASM Microbe 2024 in Atlanta, Georgia. Join us at the next ASM Microbe by visiting us at asm.org/microbe. Matters Microbial Take the TWiM Listener survey! Send your microbiology questions and comments (email or recorded audio) to twim@microbe.tv

Fungi have played an important role both in culinary and medicinal traditions for 1000s of years, but these magical living organisms are often overlooked - both for good and bad - when it comes to the future of our health and planet. What if a new heat-loving fungus takes over? What if a fungus holds the key to an anti-cancer or vaccination? We'll explore these questions and more on this week's podcast. Listen and learn: Microbial differences: bacteria, yeast, and fungi Risk of future fungal outbreaks Rewards of potential medicines and cures The known vs. unknown mystery of fungi Links Arturo Casadevall ABOUT OUR GUEST Arturo Casadevall is a physician-scientist and Bloomberg Distinguished Professor at the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine. His research focuses on fungal and bacterial pathogenesis, antibody structure-function, and improving the scientific process. He's written a number of books, the newest is, What if fungi Win? Like the Show? Leave us a review Check out our YouTube channel

Summary Dr. Arturo Casadevall discusses the fascinating world of fungi and its dual nature of being both beneficial and potentially harmful. He shares his personal journey and passion for studying fungal diseases, particularly in the context of the AIDS epidemic. The conversation explores the importance of understanding fungal diseases and the need for better drugs and vaccines. Dr. Casadevall also highlights the potential of fungi in various applications, such as biomaterials and medicine. The discussion touches on the largest organism on Earth, the interconnectedness of fungi in the ecosystem, and the intriguing concept of zombie ants. Keywords: fungi, fungal diseases, AIDS epidemic, drugs, vaccines, biomaterials, largest organism, interconnectedness, zombie ants TakeawaysFungi play a vital role in shaping and sustaining the ecosystem, but they can also be harmful and cause diseases.Fungal diseases are often overlooked and underreported, but they pose a significant threat, especially to immunocompromised individuals.Understanding and studying fungi can lead to the development of better drugs, vaccines, and biomaterials.Fungi have diverse applications, from food and medicine to eco-friendly packaging alternatives.The interconnectedness of fungi in the ecosystem and their ability to communicate underground is a fascinating area of research.While the idea of fungal epidemics causing zombie-like behavior in humans is improbable, it highlights the need for awareness and preparedness.Chapters00:00Introduction and Background 03:00The Dual Nature of Fungi07:37The Underreported Threat of Fungal Diseases13:09Separating Fungal Fiction from Reality15:49Exploring the Potential of Fungi22:10The Enormous Organism and Its Impact25:22Conclusion and Call for Knowledge Royalty Free Music from Tunetank.com Track: Surfing! by automaticbananas https://tunetank.com/track/5070-surfing!/

Dr. Arturo Casadevall discusses his fascinating book "What if Fungi Win?" Dr. Casadevall has been studying fungi for more than forty years. They are extraordinary organisms - remarkably diverse - and absolutely essential for human life. They also pose a grave threat to us with fungal diseases that affect both human beings as well as our food supply. Dr. Casadevall also talks about all that we still do not understand about fungi and the ways in which research has fallen short. "I want to help change the way we practice science," he says at one point.

Arturo Casadevall is a Bloomberg Distinguished Professor of Molecular Microbiology & Immunology and Infectious Diseases at the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine, and the Alfred and Jill Sommer Professor and Chair of the W. Harry Feinstone Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health. He is an internationally recognized expert in infectious disease research, with a focus on fungal and bacterial pathogenesis and basic immunology of antibody structure-function. He was elected a member of the National Academy of Sciences in 2022.

Dr. Arturo Casadevall from Johns Hopkins School of Public Health talks about a potential fungal epidemic in his new book, "What if Fungi Win?"Then, what if there was one overarching theory that could help explain much of our modern-day daily lives? Science journalist Tom Chivers explores the concept of the predictability of everything, based on a theorem developed by Thomas Bayes, an 18th-century Presbyterian minister and statistician.

From mushrooms to microscopic organisms, fungi represent a serious—and still relatively unexplored—threat to human health. Dr. Arturo Casadevall returns to the podcast to talk about his new book, What If Fungi Win? which looks at why certain fungal infections take off, why they're so hard to treat, and why we will most certainly see more of them with climate change and treatment-resistant strains. Learn more: https://www.press.jhu.edu/books/title/53673/what-if-fungi-win 

The zombie eco-thriller “The Last of Us” has alerted us to the threats posed by fungi. But the show is not entirely science fiction. Our vulnerability to pathogenic fungi is more real than many people imagine.  Find out what human activity drives global fungal threats, including their menace to food crops and many other species. Our high body temperature has long kept lethal fungi in check; but will climate change cause fungi to adapt to warmer temperatures and threaten our health?  Plus, a radically new way to think about these organisms, how they make all life possible, and how we might find balance again. Guests: Emily Monosson – Toxicologist who writes about changes in the natural world. A member of the Ronin Institute and a professor at the University of Massachusetts, Amherst, she is the author of “Blight: Fungi and the Coming Pandemic.” Arturo Casadevall – Microbiologist, immunologist, professor of medicine at Johns Hopkins School of Medicine. Michael Hathaway – Anthropologist, director of the Asian Studies Center at Simon Fraser University in Vancouver, Canada, and author of “What a Mushroom Lives For.”  *originally aired February 13, 2023 Big Picture Science is part of the Airwave Media podcast network. Please contact sales@advertisecast.com to inquire about advertising on Big Picture Science. You can get early access to ad-free versions of every episode by joining us on Patreon. Thanks for your support!   Learn more about your ad choices. Visit megaphone.fm/adchoices

Fungi are among us more than we realize. From the backs of frogs to our own backyard, fungi, a largely neglected group of pathogens, are becoming a prevalent and widespread concern among scientists and health experts alike. The main reason? Climate change. Joining me today on The Excerpt to discuss what's causing this explosion in disease-causing fungi is Dr. Arturo Casadevall, Chair of Molecular Microbiology & Immunology at John Hopkins Bloomberg School of Public Health.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The scientific process has the power to deliver a better world and may be the most monumental human achievement. But when it is unethically performed or miscommunicated, it can cause confusion and division. Drs. Fang and Casadevall discuss what is good science, what is bad science and how to make it better. Get the book! Thinking about Science: Good Science, Bad Science, and How to Make It Better

Today, the impressive Dr. Arturo Casadevall of Johns Hopkins University will joint #MattersMicrobial to discuss his path in science, how fungi need more study, that some fungi are literally cool, and others a looming threat.  Host: Mark O. Martin Guest: Arturo Casadevall Subscribe: Apple Podcasts, Spotify Become a patron of Matters Microbial! Links for this episode A wonderful remembrance (by multiple authors) of Lynn Margulis, and essays by Elio Schaechter (a friend of Margulis') and James Lake (a colleague).   The wonderful Tiny Earth program that uses a CURE type approach to allow students to search for new antibiotic producing microbes.  Also, a fine publication describing this worldwide program. An overview of the diverse and dizzying fungal world all around us. A publication describing how fungi dominated after every mass extinction. Giant fungi existed in Earth's past. Dr. Casadevall group's article on how fungi are cooler than the environment around them, including the “mycorefrigerator.” Evidence that high body temperatures defend against fungal disease.  Dr. Casadevall wrote an article suggesting that fungal diseases might have helped lead to the extinction of dinosaurs. Dr. Casadevall explores the possibility of fungal adaptation to higher temperatures in our warming world.   Dr. Casadevall's essay about problems with the term “pathogen.” Drs Casadevall and Fang's new book titled “Thinking About Science.” A short biography of Dr. Casadevall as well as his Wikipedia page. Dr. Casadevall's faculty website Intro music is by Reber Clark Send your questions and comments to mattersmicrobial@gmail.com

When an astroid hit earth and fungi took over, warm blooded mammals were able to survive better than cold blooded amphibians because their higher temperature gave them better resistance to fungal diseases. Since then fungi have been evolving and new fungal diseases, new medicines, and technologies have emerged. Sign up for our podcast giveaway here. Our next winner will be selected on August 24, 2023 and contacted via email.www.mushroomrevival.comWe are a functional mushroom company and make 100% certified USDA Organic and Vegan mushroom supplements. We are transparent with our lab results, and use actual fruiting bodies aka mushrooms! We provide our supplements in tincture, capsule, powder, and delicious gummy form. Energy (Cordyceps): Need a little pick-me-up before a workout or when you're picking up your kids from school? The Energy Cordyceps is the mushy match for you.Focus (Lion's Mane):  Needing a little more focus in your daily life? Lion's Mane is known to be the mushroom for the brain and may support cognitive function.Calm (Reishi): Looking for some tranquility and zen in your life? Reishi will bring you into the zen state of mind you've been searching for.Daily 10 (Mushroom Mix): It's like having 10 bodyguard mushrooms fighting off all those bad guys. This is a good place to start as it contains all of the daily mushies you need. Not sure where to begin? Take our mushroom quiz here.Use code ‘PODTREAT' for a 30% discount.

In the frenzy of research for COVID-19 prevention and treatment, there were many disagreements about what really did—or didn't—work. The nature of the debates reveals a broader problem in how data are interpreted in medicine. Dr. Arturo Casadevall and Dr. Josh Sharfstein discuss the nature of evidence and Dr. Casadevall's new paper, Misinterpretation of Clinical Research Findings and COVID-19 Mortality. You can read the paper here: https://www.acpjournals.org/doi/full/10.7326/M23-0737?af=R

Pathogens in Pop Culture: Fungal Pathogens and The Last of UsCould a fungus cause the next pandemic? If you've watched HBO's hit series ‘The Last of Us' or played the popular video game, then you may be familiar with the concept: a mass outbreak of an infectious fungus turns humans into zombies. But could the scenario played out in ‘The Last of Us' actually happen in real life? Join hosts Lauren Sauer and Rachel Lookadoo and special guest Dr. Arturo Casadevall as they take a closer look at the science behind fungal pathogens and separate myth from reality.Questions or comments for NETEC? Contact us at info@netec.org.Visit Transmission Interrupted on the web at netec.org/podcast.GuestArturo Casadevall, MD, PhDProfessor and Chair, Department of Molecular Microbiology and Immunology, Johns Hopkins School of Public Health. Dr. Casadevall focuses on host defense mechanisms, how fungi cause disease, and in the development of antibody-based therapies for infectious diseases.Twitter: https://twitter.com/ACasadevall1HostsLauren Sauer, MScLauren is an Associate Professor in the College of Public Health, Department of Environmental, Agricultural, and Occupational Health, at the University of Nebraska Medical Center and Core Faculty of the UNMC Global Center for Health Security. She is an Adjunct Associate Professor of Emergency Medicine in the Johns Hopkins School of Medicine, and the director of the Special Pathogens Research Network.She previously served as Director of Operations for the Johns Hopkins Office of Critical Event Preparedness where she ran the inpatient COVID19 biobank and served on the COVID19 research steering committee for JHU. Lauren's research focuses on human subjects research in bio-emergencies and disasters, in particular, ethical implementation of research and navigating the regulatory environment. The goal of her research is to provide health care facilities with the tools needed to conduct a clinical and operational research response in emergencies.Rachel Lookadoo, JDRachel Lookadoo is an Assistant Professor in the Epidemiology department of the College of Public Health at the University of Nebraska Medical Center, and serves as the Deputy Director of the Center for Biosecurity, Biopreparedness, and Emerging Infectious Diseases. She also acts as the Director of Public Health Policy for the Water, Climate, and Health program at the University of Nebraska Medical Center. Ms. Lookadoo's background is as an attorney, and she focuses on the various legal and regulatory issues that can arise in emergency preparedness and response. She specializes in public health impacts of climate change, healthcare surge events, isolation/quarantine law, crisis standards of care, infectious disease response, and general legal preparedness. Ms. Lookadoo also conducts emergency preparedness trainings and assessments for public health departments and healthcare facilities nationally. Ms. Lookadoo received her Juris Doctor degree from American University Washington College of Law, and her Bachelor's degree from Baylor University.ResourcesCan a Fungus Cause a COVID-Style Pandemic? https://www.medpagetoday.com/popmedicine/popmedicine/103449?vrw=noWhy Fungal Diseases Are an Increasing Threat: https://magazine.jhsph.edu/2022/why-fungal-diseases-are-increasing-threat NETEC Resource Library: https://repository.netecweb.orgAbout NETECA...

Understanding how infectious diseases spread in the past is important to understanding how they affect populations today. The difficulty lie in piecing together information given that so little is known about how microbes spread historically. Applying academic rigor with scientific assessment, two microbiologists teamed with an archaeologist to look at different types of evidence — genetics, anthropology, paleontology and climate — in an attempt to explain how the fungus that causes Valley fever, Coccidioides immitis, ended up in a specific area of Washington state. The review article in mBio by Drs. David Engelthaler, James C. Chatters and Arturo Casadevall details their approach from a historical perspective, applying what they knew about the biology and epidemiology of C. immitis, which led them to propose a new theory for why it has emerged in that region of Washington. Today, a great deal of discussion around the spread of diseases and the expansion of their habitats focuses on the effects of global warming. And while climate change does have an impact on different environments and habitats, this investigation sought to understand how and why different microbes, like fungi, move from one place to another through the lens of modern biology. Their final analysis, climate change may not always be the reason behind the spread of diseases, but it can reveal past events that could be dangerous. Engelthaler explains more in this edition of TGen Talks.

Arturo Casadevall returns to TWiV to explain the use of convalescent serum to treat COVID-19 patients, and the need to support virology at a time when more regulation of experiments is envisioned. Hosts: Vincent Racaniello, Alan Dove, and Rich Condit Guest: Arturo Casadevall Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Register for ASV 2023 MicrobeTV Discord Server Early treatment of COVID-19 with convalescent plasma (NEJM) Neutralization of SARS-CoV-2 by convalescent plasma (Nat Comm) Convalescent COVID-19 plasma for immunocompromised patients (JAMA Net Open) Virology under the microscope (mSphere) Virology in peril (mSphere) Emil von Behring Nobel Lecture Letters read on TWiV 987 Timestamps by Jolene. Thanks! Weekly Picks Rich - Flammarion engraving Alan - What Remains of Edith Finch Vincent - The CDC's Long-Covid Deception Listener Pick Bill - General Relativity For Babies Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv

The Smart 7 Ireland Edition is the daily news podcast that gives you everything you need to know in 7 minutes, at 7am, 7 days a week… Consistently appearing in Ireland's Daily News charts, we're a trusted source for people every day. If you're enjoying it, please follow, share or even post a review, it all helps… Today's episode includes references to the following guests:Arturo Casadevall, - Professor of microbiology and immunology at the Johns Hopkins School of MedicineAndrej Spec - Associate Professor of Infectious Diseases at Washington University School of MedicineDr Borna Bonakdarpour - Associate Professor of Neurology at Northwestern UniversityShashank Samala - CEO of Heirloom Carbon CaptureRob Niven - CEO of Carbon CureBen Lamm - CEO of Colossal BiosciencesDr Sarah-Elizabeth Byosiere - Director of the Thinking Dog Center at Hunter CollegeContact us over at Twitter or visit www.thesmart7.com Presented by Ciara Revins, written by Oliva Davies and Liam Thompson and produced by Daft Doris. Hosted on Acast. See acast.com/privacy for more information.

The Smart 7 is a daily podcast that gives you everything you need to know in 7 minutes, at 7 am, 7 days a week... With over 12 million downloads and consistently charting, including as No. 1 News Podcast on Spotify, we're a trusted source for people every day. If you're enjoying it, please follow, share, or even post a review, it all helps...Today's episode includes the following guests: Arturo Casadevall, - Professor of microbiology and immunology at the Johns Hopkins School of MedicineAndrej Spec - Associate Professor of Infectious Diseases at Washington University School of MedicineDr Borna Bonakdarpour - Associate Professor of Neurology at Northwestern UniversityShashank Samala - CEO of Heirloom Carbon CaptureRob Niven - CEO of Carbon CureBen Lamm - CEO of Colossal BiosciencesDr Sarah-Elizabeth Byosiere - Director of the Thinking Dog Center at Hunter College In Ireland? Why not try our Ireland Edition?Contact us over at Twitter or visit www.thesmart7.comPresented by Jamie East, written by Olivia Davies and produced by Daft Doris. Hosted on Acast. See acast.com/privacy for more information.

Early on in the pandemic plasma collected from people who'd had Covid-19 and survived, so called convalescent plasma, was used to treat others, with mixed success. Now that new variants have emerged that can escape antibodies stimulated by vaccines and most monoclonals aren't useful, Arturo Casadevall, a convalescent plasma expert at Johns Hopkins, says the […]

Dr. Arturo Casadevall is a Bloomberg Distinguished Professor of Molecular Microbiology & Immunology and Infectious Diseases, as well as a recent inductee to the National Academy of Sciences. Today, he joins us to discuss his research into convalescent plasma in the fight against COVID-19.

Early in the pandemic, clinicians began to treat people sick with COVID-19 with the plasma of people who have recovered from COVID-19. The idea was that protective antibodies in the plasma would help prevent severe illness and death. Nearly two years later, the evidence is in—and it's being hotly debated. Dr. Arturo Casadevall returns to the podcast to talk with Dr. Josh Sharfstein about the results of the COVID-19 Plasma Project and his take on divergent recommendations about using plasma as a therapy.

Brace yourself for heatwave “Lucifer.” Dangerous deadly heatwaves may soon be so common that we give them names, just like hurricanes. This is one of the dramatic consequences of just a few degrees rise in average temperatures. Also coming: Massive heat “blobs” that form in the oceans and damage marine life, and powerful windstorms called “derechos” pummeling the Midwest.  Plus, are fungal pathogens adapting to hotter temperatures and breaching the 98.6 F thermal barrier that keeps them from infecting us? Guests: Kathy Baughman McLeod – director and senior vice president of the Adrienne Arsht-Rockefeller Foundation Resilience Center at The Atlantic Council Pippa Moore – Marine ecologist at Newcastle University in the U.K. Ted Derouin – Michigan farmer Jeff Dukes – Ecologist and director of Purdue Climate Change Research Center at Purdue University. Arturo Casadevall – Molecular microbiologist and immunologist at the Johns Hopkins School of Medicine Originally aired October 19, 2020 Big Picture Science is part of the Airwave Media podcast network. Please contact sales@advertisecast.com to inquire about advertising on Big Picture Science. You can get early access to ad-free versions of every episode by joining us on Patreon. Thanks for your support!   Learn more about your ad choices. Visit megaphone.fm/adchoices

The COVID-19 pandemic has been already in our lives since late 2019 and the variants surge is rapidly increasing. Is there anything we can learn from the experience? Fast forward to the fall of 2021, what are the recommendations for Hospitals and Laboratories around the world for the current pandemic and future spread of diseases? In this podcast episode, we will have a conversation with Dr. Arturo Casadevall an infectious disease specialist and Bloomberg Distinguished Professor at Johns Hopkins University about learnings from this pandemic, vaccines, variants, and how antibody testing can play a key role. About our Speaker: Dr. Arturo Casadevall is a professor of medicine at the Johns Hopkins School of Medicine. He holds a joint appointment in molecular microbiology and immunology at the Johns Hopkins Bloomberg School of Public Health. His research focuses on how microbes cause disease and how the immune system defends itself. Dr. Casadevall serves as chair of the W. Harry Feinstone Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health. He received his M.S., Ph.D., and M.D. from New York University. His team is currently engaged in understanding how hosts defend against the fungus Cryptococcus neoformans. Dr. Casadevall's work has been recognized with numerous awards, including the American Society for Microbiology Founders Distinguished Service Award, the National Institutes of Health Merit Award, and the Rhoda Benham Award from the Medical Mycology Society of America.  He was elected to the National Academy of Medicine and the American Academy of Arts and Sciences.

Chair of Molecular Microbiology and Immunology at Johns Hopkins School of Public Health, Dr. Arturo Casadevall, joins Dr. Marc Siegel and discusses the studies on Convalescent Plasma and when it is most effective in treating COVID-19 patients. He also shares his thoughts on natural versus vaccinated protection against the virus.

Fungal diseases are rare but, once diagnosed, incredibly hard to treat and often fatal. The overwhelming surge of COVID-19 cases in India has given rise to mucormycosis, also called “black fungus” for the appearance of the lesions caused by the infection. Dr. Arturo Casadevall talks with Stephanie Desmon about this and other fungal diseases, why COVID patients in India are particularly vulnerable, why treatments are slow and often ineffective, and why the pharmaceutical industry hasn't invested more in treating these often deadly infections.

Arturo Casadevall joins TWiV to discuss the use of convalescent plasma to treat COVID-19, including a history of the process, how plasma is prepared and tested, why it is difficult to conduct randomized clinical trials, how this treatment has fared and his hopes for the future. Hosts: Vincent Racaniello, Alan Dove, Rich Condit, and Brianne Barker Guest: Arturo Casadevall Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Victory for Scientific Pragmatism (New Atlantis) Convalescent plasma levels and risk of COVID-19 death (NEJM) COVID-19 convalescent plasma safety indicators (JCI) COVID-19 convalescent plasma reduces mortality (medRxiv) Pfizer mRNA vaccine in 12-15 year olds (Pfizer) NIDO 2021 Symposium ASV hosts free COVID-19 Vaccine Education Town Halls (register here) Letters read on TWiV 739 Timestamps by Jolene. Thanks! Weekly Picks Brianne – The Ocean’s Youngest Monsters Are Ready for Glamour Shots Alan – 7 Billion Humans Rich – 15 Fascinating Animal X-Rays From the Oregon Zoo Vincent – Respiratory pathogen trends Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv

Arturo Casadevall joins TWiV to discuss the use of convalescent plasma to treat COVID-19, including a history of the process, how plasma is prepared and tested, why it is difficult to conduct randomized clinical trials, how this treatment has fared and his hopes for the future. Hosts: Vincent Racaniello, Alan Dove, Rich Condit, and Brianne Barker Guest: Arturo Casadevall Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Victory for Scientific Pragmatism (New Atlantis) Convalescent plasma levels and risk of COVID-19 death (NEJM) COVID-19 convalescent plasma safety indicators (JCI) COVID-19 convalescent plasma reduces mortality (medRxiv) Pfizer mRNA vaccine in 12-15 year olds (Pfizer) NIDO 2021 Symposium ASV hosts free COVID-19 Vaccine Education Town Halls (register here) Letters read on TWiV 739 Timestamps by Jolene. Thanks! Weekly Picks Brianne – The Ocean’s Youngest Monsters Are Ready for Glamour Shots Alan – 7 Billion Humans Rich – 15 Fascinating Animal X-Rays From the Oregon Zoo Vincent – Respiratory pathogen trends Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv

It's been just over a year since the first coronavirus case was reported in the United States, and the virus continues to spread rapidly through our communities. Last spring, we spoke with Dr. Arturo Casadevall – an infectious disease specialist and Bloomberg Distinguished Professor at Johns Hopkins University who was leading a team of experts to develop a convalescent blood plasma therapy for health care workers and for early treatment of COVID-19 patients. To help launch this research, Bloomberg Philanthropies, Maryland Governor Larry Hogan and Johns Hopkins worked together to provide early funding for the potential therapeutic uses of convalescent plasma. Fast forward to earlier this month, when the Mayo Clinic published a study showing antibodies in convalescent blood plasma therapy help lower mortality rates in over 3,000 coronavirus patients. While the COVID-19 vaccine continues to roll out, blood plasma therapy can help to save the lives of patients already infected with the coronavirus - and the Red Cross reports that hospital distributions of convalescent plasma for COVID-19 patents have increased by 250% since October. On this episode, Dr. Casadevall joins Dr. Jessica Leighton of the Bloomberg Philanthropies public health team to tell us more about how his research has progressed over the past few months, if convalescent blood plasma therapy and the vaccine are effective for new coronavirus strains, and how you could help save lives in your community. If you’ve recovered from COVID-19 and are interested in donating your blood plasma to others, please visit redcrossblood.org.

En este especial de fin de año se analiza cómo la opacidad oficial, relacionada a la pandemia del coronavirus, afecta negativamente a los pueblos latinoamericanos. Invitados: Dr. Rafael Amador, epidemiólogo de Nicaragua y el Dr. Arturo Casadevall, profesor e investigador de la Universidad Johns Hopkins. Conduce Gonzalo Abarca, Voz de América.

Dr. Casadevall is the chair of the Molecular Microbiology & Immunology department at Johns Hopkins University. And Dr. Panth is a Professor of Epidemiology, Biostatistics, and Pediatrics at Michigan State University. Today, they will discuss their recent Op-Ed in the Wall Street Journal, in which they explore why it is often so hard for scientists to reach consensus about COVID-19. In their Wall Street Journal Op-Ed, the doctors asked two questions: What are the standards of evidence in medicine and how do they apply in the particular case of convalescent plasma for treating COVID-19? The gold standard in medical research is of course experimentation and double blind clinical trials. But as the doctors argue, we should be more open to the benefits of medical care born of observation, especially, as in the case of COVID, where greater speed is needed to find treatments. Go to NoLabels.org to learn more about how we are bringing together a bipartisan group of public and private leaders working to solve America’s toughest problems.Follow No Labels and Gridlock Break Twitter • Facebook • Instagram

COVID-19 mortality rates are falling and better treatments are one of the main reasons why. Dr. Arturo Casadevall returns to the podcast to talk with Stephanie Desmon about where we are with different treatments and their successes, ongoing clinical trials, why some treatments are harder than others to produce, and whether we’ll continue to see investments in treatments when a vaccine is available.

Brace yourself for heatwave “Lucifer.” Dangerous deadly heatwaves may soon be so common that we give them names, just like hurricanes. This is one of the dramatic consequences of just a few degrees rise in average temperatures. Also coming: Massive heat “blobs” that form in the oceans and damage marine life, and powerful windstorms called “derechos” pummeling the Midwest.  Plus, are fungal pathogens adapting to hotter temperatures and breaching the 98.6 F thermal barrier that keeps them from infecting us? Guests: Kathy Baughman McLeod – director and senior vice president of the Adrienne Arsht-Rockefeller Foundation Resilience Center at The Atlantic Council Pippa Moore – Marine ecologist at Newcastle University in the U.K. Ted Derouin – Michigan farmer Jeff Dukes – Ecologist and director of Purdue Climate Change Research Center at Purdue University. Arturo Casadevall – Molecular microbiologist and immunologist at the Johns Hopkins School of Medicine  

Six years ago, a new infection began popping up in four different hospitals on three different continents, all around the same time. It wasn’t a bacteria, or a virus. It was ... a killer fungus. No one knew where it came from, or why. Today, the story of an ancient showdown between fungus and mammals that started when dinosaurs disappeared from the earth. Back then, the battle swung in our favor (spoiler alert!) and we’ve been hanging onto that win ever since. But one scientist suggests that the rise of this new infectious fungus indicates our edge is slipping, degree by increasing degree. This episode was reported by Molly Webster, and produced by Molly and Bethel Habte, with production help from Tad Davis. Special thanks to Julie Parsonnet and Aviv Bergman.  Support Radiolab today at Radiolab.org/donate.   Further Fungus Reading: NYTimes feature on the mysterious rise of Candida auris.   Arturo's paper: “On the emergence of Candida auris, Climate Change, Azoles, Swamps, and Birds”, by Arturo Casadevall, et al. “On the Origins of a Species: What Might Explain the Rise of Candida auris?”, a report from the CDC.  

Why Convalescent Plasma for COVID-19? In this episode of Ortho Science BYTES host, Matt Dawson discuss why COVID-19 Convalescent Plasma has been used as a treatment and what are the scientific and clinical basis for its use with Dr. Lily Li.   About our Speaker: Dr. Lily Li is the Medical Safety Officer at Ortho Clinical Diagnostics responsible for evaluating potential medical risks and guiding risk mitigation of all marketed products. She also serves as a Medical Director at Medical and Scientific Affairs providing evidence-based support to Ortho’s current and future products. Prior to joining Ortho, Lily had ten years of pharmaceutical R&D experience in Johnson & Johnson and led and advanced multiple programs of biologics and cell therapies through development. Lily obtained her Medical Degree from Peking University, China, and her Ph.D. in Immunology from the University of Alberta, Canada. She completed her post-doctoral training at the Scripps Research Institutes, San Diego. Lily is the author of more than 40 scientific articles and has filed 17 patent applications. References and Links: Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma; Shen at al. JAMA. 2020;323(16):1582-1589. Published online March 27, 2020.The feasibility of convalescent plasma therapy in severe COVID-19 patients: a pilot study, Duan et al, Mar 2020, medRxiv preprint doi: https://doi.org/10.1101/2020.03.16.20036145Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial, Li et al, JAMA, 2020 Jun 3. doi: 10.1001/jama.2020.10044.Convalescent plasma treatment of severe COVID-19: A matched 1 control study, S. T. H. Liu, et al, May 22, 2020, medRxiv preprint doi: https://doi.org/10.1101/2020.05.20.20102236. Convalescent Plasma to Treat COVID-19. Possibilities and Challenges; John D. Roback, MD, PhD; Jeannette Guarner, MD. JAMA April 28, 2020 Volume 323, Number 16The convalescent sera option for containing COVID-19 Arturo Casadevall, Liise-anne Pirofski. J Clin Invest. 2020;130(4):1545-1548. FDA site https://www.fda.gov/

Dr. Arturo Casadevall has been promoting “convalescent plasma” as a treatment for disease since before the pandemic took hold in the U.S. He explains what it is, how it helps with COVID-19, and why we need much, much more.

Dr. Josh Sharfstein gets an update from Dr. Arturo Casadevall about the innovative idea of using convalescent serum from patients who have recovered from COVID-19 to help others. Since we last heard from him, Dr. Casadevall has launched a plasma project that, along with others across the US, has helped over 35,000 COVID-19 patients. Casadevall also talks about how data from the project can help with vaccine and other therapy developments

Transcript“With penicillin, for example, you needed a few days to begin to get better. With antibodies, these people got better within hours, almost as if the antibody was mediating an antitoxin effect.” - Arturo CasadevallIn today’s episode, our host Dr. Celine Gounder speaks with Arturo Casadevall, Chair of the Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health, about convalescent plasma, the transfer of antibodies from a disease survivor to a disease patient. They discuss the history of convalescent plasma transfer, how it has been used in the past during other infectious disease outbreaks, such as diphtheria and measles, and how the invention of antibiotics led to the decline of this treatment method in the United States. They also talk about the current research studies being done to test the effectiveness of this treatment method on COVID-19 patients. Our host also speaks with Michael Busch,  the Director of the Vitalant Research Institute, about how convalescent plasma transfer is currently being used as a treatment for COVID-19 patients at different stages of infection. They also discuss the process of convalescent plasma donation, something that anyone who has recovered from COVID-19 and now has antibodies can do.Listener Q&A: Should I go on an out-of-state trip with my husband’s family? I am antibody negative, how can I minimize the risk of becoming exposed to COVID-19 on the trip?This podcast was created by Just Human Productions. We're powered and distributed by Simplecast. We're supported, in part, by listeners like you.#SARSCoV2 #COVID19 #COVID #coronavirus

Dr. Arturo Casadevall and colleagues at Johns Hopkins University and around the country have been working around the clock to develop a convalescent serum therapy to treat COVID-19 using blood plasma from recovered patients. If all goes well with the current U.S. trials, thousands of survivors might soon line up to donate their antibody-rich plasma. In this episode of our series around Bloomberg Philanthropies’ COVID-19 response, Dr. Casadavall joined Dr. Jessica Leighton, from our public health team, to discuss how blood plasma has been used to treat infectious disease outbreaks in the past, what makes blood plasma treatment different from a vaccine, how donating your blood plasma could help your community, and what’s giving researchers hope right now.

COVID-19 Virus Breakthrough– Convalescent Plasma and What is Forest Bathing & Can It Boost Immunity Against Viruses? COVID-19 Health Care Breakthroughs – Convalescent PlasmaNewt's WorldIn the midst of the Coronavirus health crisis, doctors and scientists are searching for new therapies until there is a vaccine or cure.  Newt interviews Dr. Arturo Casadevall about convalescent plasma treatments for critical COVID-19 patients.  Could it help save lives? Coronavirus Pandemic Update 56: What is “Forest Bathing” & Can It Boost Immunity Against Viruses?https://youtu.be/PgDjVEpEOdQ MedCram - Medical Lectures Explained CLEARLYCOVID-19 Update 56 with Roger Seheult, MD of https://www.MedCram.com A series of joint studies from Stanford University School of Medicine and several medical schools and institutions in Japan demonstrated that exposure to “phytoncides” released by trees and plants may boost immunity by increasing natural killer cell quantity and activity among other effects. Dr. Seheult illustrates how these studies were conducted as exposure to forests (forest bathing) may fall into the category of additional things we can do (and that don’t cause harm) to potentially help prevent viral infections such as COVID-19. Also discussed is how the state of New York decided to count some deaths that have occurred at home that were presumed to be from COVID-19 but did not have a positive test. Links referenced in this video: Johns Hopkins Tracker - https://gisanddata.maps.arcgis.com/ap... Worldometer - https://www.worldometers.info/coronav... Forest Bathing - https://journals.sagepub.com/doi/pdf/... Visiting a Forest, But Not a City - https://journals.sagepub.com/doi/pdf/... Effect of Phytoncide - https://journals.sagepub.com/doi/pdf/... Some previous videos from this series (visit MedCram.com for the full series): - Coronavirus Pandemic Update 55: How COVID-19 Infection Attacks The Immune System & Differs From HIV: https://youtu.be/8NffZAGELGg - Coronavirus Pandemic Update 54: COVID-19 Antibody vs. PCR Testing; When to Relax Social Distancing?: https://youtu.be/kgzFAdYwYLM - Coronavirus Pandemic Update 53: Anticoagulation; Can Mechanical Ventilation Make COVID 19 Worse?: https://youtu.be/o8aG63yigjA - Coronavirus Pandemic Update 52: Ivermectin Treatment; Does COVID-19 Attack Hemoglobin?: https://youtu.be/qc6VV7ue4cE - Coronavirus Pandemic Update 51: State by State Projections; Ultrasound to Diagnose COVID19 Pneumonia: https://youtu.be/E7MufS6dnJw - Coronavirus Pandemic Update 50: Dip in Daily New Deaths; Research on Natural Killer Cells & COVID-19: https://youtu.be/fya6Zwxch88 - Coronavirus Pandemic Update 49: New Data on COVID-19 vs Other Viral Infections (Ventilator Outcomes): https://youtu.be/uaIzj3s3p4A - Coronavirus Pandemic Update 48: Curve Flattening in California, PPE in the ICU, Medication Trials: https://youtu.be/JN-8bGB1cLM - Coronavirus Pandemic Update 47: Searching for Immunity Boosters & Possible Lessons From Spanish Flu: https://youtu.be/H1LHgyfPPQ8 -Coronavirus Pandemic Update 46: Can Hot/Cold Therapy Boost Immunity? More on Hydroxychloroquine https://youtu.be/EFRwnhfWXxo - Coronavirus Pandemic Update 45: Sharing Ventilators, More on Sleep, Immunity, & COVID-19 Prevention https://youtu.be/G1zsE9_85i4 - Coronavirus Pandemic Update 44: Loss of Smell & Conjunctivitis in COVID-19, Is Fever Helpful? https://youtu.be/A4eu-h_owaI - Coronavirus Pandemic Update 43: Shortages, Immunity, & Can a TB Vaccine (BCG) Help Prevent COVID-19? https://youtu.be/LqKwAIIy-Mo - Coronavirus Pandemic Update 42: Immunity to COVID-19 and is Reinfection Possible? https://youtu.be/q4P91VrfPGw - Coronavirus Pandemic Update 41: Shelter In Place, FDA Investigates Hydroxychloroquine for COVID-19: https://youtu.be/hPz5KxgI_K4 - Coronavirus Pandemic Update 40: Ibuprofen and COVID-19 (are NSAIDs safe?), trials of HIV medications: https://youtu.be/dT6mHi_8V5E - Coronavirus Pandemic Update 39: Rapid COVID-19 Spread with Mild or No Symptoms, More on Treatment: https://youtu.be/AToF8O5T86s - Coronavirus Pandemic Update 38: How Hospitals & Clinics Can Prepare for COVID-19, Global Cases Surge: https://youtu.be/MoisrCTu0SY - Coronavirus Pandemic Update 37: The ACE-2 Receptor - The Doorway to COVID-19 (ACE Inhibitors & ARBs): https://youtu.be/1vZDVbqRhyM - How Coronavirus Kills: Acute Respiratory Distress Syndrome (ARDS) & Treatment: https://youtu.be/okg7uq_HrhQ Many other videos on COVID-19 (coronavirus outbreak, coronavirus symptoms, Spanish Flu pandemic, influenza, coronavirus epidemic, coronavirus updates, coronavirus vaccine, boosting the immune system with forest bathing, ultrasound to diagnose COVID-19) and other medical topics (ECG Interpretation, hypertension, anticoagulation, DKA, acute kidney injury, influenza, measles, mechanical ventilation, etc.) at MedCam.com Speaker: Roger Seheult, MD Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine. MedCram provides videos to a variety of medical schools, education programs, and institutions (please contact us at customers@medcram.com if you are interested) Media Contact: emayer@medcram.com Media contact info: https://www.medcram.com/pages/media-c... MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor. #COVID19 #SARSCoV2 #Coronavirus --------------------------------------------------------------------  HELP ACU SPREAD THE WORD! Ways to subscribe to the American Conservative University PodcastClick here to subscribe via iTunesClick here to subscribe via RSSYou can also subscribe via StitcherIf you like this episode head on over to iTunes and kindly leave us a rating, a review and subscribe! People find us through our good reviews. FEEDBACK + PROMOTIONYou can ask your questions, make comments, submit ideas for shows and lots more. Let your voice be heard.Email us at americanconservativeuniversity@americanconservativeuniversity.comNote- ACU Students and Alumni are asked to commit to donating Platelets and Plasma.  Make an Appointment Today! Call Your local Hospital or The Red Cross at 1-800-733-2767

In the midst of the Coronavirus health crisis, doctors and scientists are searching for new therapies until there is a vaccine or cure.  Newt interviews Dr. Arturo Casadevall about convalescent plasma treatments for critical COVID-19 patients.  Could it help save lives?

Bloomberg News Global Macro Strategist Vincent Cignarella and Peter Tchir, Head of Macro Strategy at Academy Securities, discuss a surge in U.S. jobless claims and share the latest on where the economy stands. Dr. Arturo Casadevall, Chair of the Department of the Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health, provides an update on the coronavirus. Bloomberg Businessweek Editor Joel Weber and Businessweek Assistant Managing Editor Jim Ellis give their insight on Boeing asking Washington for help that critics say the company doesn’t deserve. And we Drive to the Close with Ryan Detrick, Senior Market Strategist at LPL Financial. Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.

Bloomberg News Global Macro Strategist Vincent Cignarella and Peter Tchir, Head of Macro Strategy at Academy Securities, discuss a surge in U.S. jobless claims and share the latest on where the economy stands. Dr. Arturo Casadevall, Chair of the Department of the Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health, provides an update on the coronavirus. Bloomberg Businessweek Editor Joel Weber and Businessweek Assistant Managing Editor Jim Ellis give their insight on Boeing asking Washington for help that critics say the company doesn't deserve. And we Drive to the Close with Ryan Detrick, Senior Market Strategist at LPL Financial. Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

In the last chapter of his brilliant book “Range,” David Epstein profiled Arturo Casadevall, MD, PhD, and the chair of molecular microbiology and immunology at Johns Hopkins. It’s a book about the people and conditions that lead to extraordinary performance, and it’s coming to life right now: Dr. Casadevall has kicked off a major consortium of labs targeting a short-term COVID-19 therapy, made from the plasma of recovered COVID-19 patients, with the potential to be deployed quickly. David joined us at the top of the show to explain.And then (talk about “range”), we welcomed Noah Galuten, a remarkable chef who guided the Abbotts in making killer tacos with the stuff we happen to have in our quarantine-time fridge.Here’s the archived video: This is a public episode. Get access to private episodes at www.truehoop.com/subscribe

Fungi, radiation shielding, and current microbiology research are just a few of the topics we get into on this episode of the Learning with Lowell science, biotech, and space podcast. 

Say cluck ONE more time motherclucker!It's a chik-a-licious episode this time around! Flemming's not-at-all unusual obsession with chickens has found its way into our studio. Again. And it's lovely! He's gonna tell you about chicken language.Our spiritual substitute for Robin has joined us for his english debut where he develops your knowledge and understanding of radioactive-loving microbes. Give a warm welcome to Nikolaj Hansen.And finally, Mark has found the pinnacle of scientific research. But look out for his fake news! Its in there somewhere.Buy our merch! bit.ly/spækshopFree shipping between 29th of January till 2th of February with coupon code SHIP4U19Rate us on iTunes! bit.ly/spækitunesSend us water-hilarious science (it's an inside joke) or ask a question on facebook, twitter, or to spaekbraettet@gmail.comIt's our own music now, baby!Citations:Christopher S. Evans & Linda Evans (1999) Chicken food calls are functionally referential Mabuchi (2011) Frictional Coefficient under Banana SkinEkaterina Dadachova and Arturo Casadevall (2008) Ionizing Radiation: how fungi cope, adapt, and exploit with the help of melanin Dadachova et al. (2007) Ionizing Radiation Changes the Electronic Properties of Melanin and Enhances the Growth of Melanized Fungi J. R. Battista (1997) AGAINST ALL ODDS: The Survival Strategies of Deinococcus radiodurans Support the show (https://spaekbraettet.10er.app/)

This episode addresses further definitions of life, the end of the dinosaurs, and the emergence of the mammal, along with the partnership that they made with fungi to do it. This story is inspired by a seminar by Dr. Arturo Casadevall from John's Hopkins. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/keenan-t/message

At Microbe 2017 in New Orleans, the TWiM team speaks with Arturo Casadevall about his thoughts on the pathogenic potential of a microbe, rigorous science, funding by lottery, and moonshot science. Hosts: Vincent Racaniello, Michael Schmidt, Elio Schaechter and Michele Swanson. Guest: Arturo Casadevall Subscribe to TWiM (free) on iPhone, Android, RSS, or by email. You can also listen on your mobile device with the Microbeworld app. Become a patron of TWiM. Links for this episode Pathogenic potential of a microbe (mSphere) Rigorous science (mBio) Funding by lottery (mBio) Moonshot science (mBio) Send your microbiology questions and comments (email or recorded audio) to twim@microbe.tv

At Microbe 2017 in New Orleans, the TWiM team speaks with Arturo Casadevall about his thoughts on the pathogenic potential of a microbe, rigorous science, funding by lottery, and moonshot science. Hosts: Vincent Racaniello, Michael Schmidt, Elio Schaechter and Michele Swanson. Guest: Arturo Casadevall Subscribe to TWiM (free) on iPhone, Android, RSS, or by email. You can also listen on your mobile device with the Microbeworld app. Become a patron of TWiM. Links for this episode Pathogenic potential of a microbe (mSphere) Rigorous science (mBio) Funding by lottery (mBio) Moonshot science (mBio) Send your microbiology questions and comments (email or recorded audio) to twim@microbe.tv

At Microbe 2017 in New Orleans, the TWiM team speaks with Arturo Casadevall about his thoughts on the pathogenic potential of a microbe, rigorous science, funding by lottery, and moonshot science. Hosts: Vincent Racaniello, Michael Schmidt, Elio Schaechter and Michele Swanson. Guest: Arturo Casadevall Subscribe to TWiM (free) on iPhone, Android, RSS, or by email. You can also listen on your mobile device with the Microbeworld app. Become a patron of TWiM. Links for this episode Pathogenic potential of a microbe (mSphere) Rigorous science (mBio) Funding by lottery (mBio) Moonshot science (mBio) Send your microbiology questions and comments (email or recorded audio) to twim@microbe.tv

At Microbe 2017 in New Orleans, the TWiM team speaks with Arturo Casadevall about his thoughts on the pathogenic potential of a microbe, rigorous science, funding by lottery, and moonshot science. Hosts:  Vincent Racaniello, Michael Schmidt, Michele Swanson and Elio Schaechter. Watch the video version recorded live at ASM Microbe 2017! Subscribe to TWiM (free) on iPhone, Android, RSS, or by email. You can also listen on your mobile device with the Microbeworld app. Become a patron of TWiM. Links for this episode Pathogenic potential of a microbe (mSphere) Rigorous science (mBio) Funding by lottery (mBio) Moonshot science (mBio) Send your microbiology questions and comments (email or recorded audio) to twim@microbe.tv

In the latest episode of the science communication show Public Health United, Nina and guest Dr. Rada Cordero discuss how difficult it can be for scientists to express the importance of their work, especially when it isn't easily definable, at first glance, in terms of health importance. We also learn about Rada's work in the lab of Dr. Arturo Casadevall at Johns Hopkins School of Public Health on how melanin-a molecule found in many different forms of life-protects organisms that live in extreme environments like in the poles or even in radioactive sites like Chernobyl. This work on melanin is particularly exciting as scientists like Rada are trying to figure out how to use the unique properties of melanin in many different biophysical applications like detecting life on other planets, biosensors, and living in extreme conditions i.e. Mars or Chernobyl. Rada's passion for working at the intersection of biology and physics is clear in our latest episide. Check www.publichealthunited.org for related episode links. Please follow us on Twitter (PHUpodcast) and Facebook.

Science is in crisis from external and internal forces. Poor PhD curriculum and science communication with the public are in dire need of improvement according to our latest podcast guest, Dr. Arturo Casadevall. Dr. Casadevall recently became chair of the Department of Molecular Microbiology and Immunology at the Johns Hopkins School of Public Health. We are thrilled to share with you this thought provoking interview on the current and future state of Science and Science Communication with Dr. Casadevall.

How vulnerable are we to bioterrorism? Arturo Casadevall, M.D., Ph.D., chair of microbiology and immunology at Einstein and deputy director of the Northeast Biodefense Center, discusses the progress and the barriers in the perpetual fight against biological attacks—by man and by nature.

Watch Dr. Jeff Fox, Features Editor for Microbe Magazine talk with Arturo Casadevall, MD, Ph.D., the editor-in-chief of mBio, the new online, open-access journal from the American Society for Microbiology, about an opinion/hypothesis article he co-authored suggesting that rising global temperatures will result in new fungal infections for mammals living in temperate climates. This video was recorded live on May 24, 2010, at the American Society for Microbiology's 110th General Meeting in San Diego, Ca.

Watch Dr. Jeff Fox, Features Editor for Microbe Magazine talk with Arturo Casadevall, MD, Ph.D., the editor-in-chief of mBio, the new online, open-access journal from the American Society for Microbiology, about an opinion/hypothesis article he co-authored suggesting that rising global temperatures will result in new fungal infections for mammals living in temperate climates. This video was recorded live on May 24, 2010, at the American Society for Microbiology's 110th General Meeting in San Diego, Ca.

Watch Dr. Jeff Fox, Features Editor for Microbe Magazine talk with Arturo Casadevall, MD, Ph.D., the editor-in-chief of mBio, the new online, open-access journal from the American Society for Microbiology, about an opinion/hypothesis article he co-authored suggesting that rising global temperatures will result in new fungal infections for mammals living in temperate climates. This video was recorded live on May 24, 2010, at the American Society for Microbiology's 110th General Meeting in San Diego, Ca.

October 15, 2009 — The fact that they eat a lot - and often - may explain why most people and other mammals are protected from the majority of fungal pathogens, according to research from Albert Einstein College of Medicine of Yeshiva University.

Ekaterina Dadachova, Ph.D., the Sylvia & Robert S. Olnick Faculty Scholar in Cancer Research, discusses the technology she invented with Arturo Casadevall, M.D., Ph.D., and Joshua Nosanchuk, M.D. The technology, radioimmunotherapy of metastatic melanoma with radiolabeled melanin-binding antibodies, was invented at Einstein and is now in clinical trials sponsored by Pain Therapeutics. (September 24, 2009)